Why Monoamine Oxidase B Preferably Metabolizes <i>N</i>-Methylhistamine over Histamine: Evidence from the Multiscale Simulation of the Rate-Limiting Step
Histamine levels in the human brain are controlled by rather peculiar metabolic pathways. In the first step, histamine is enzymatically methylated at its imidazole <i>N</i><sup>τ</sup> atom, and the produced <i>N</i>-methylhistamine undergoes an oxidative deaminat...
Main Authors: | Aleksandra Maršavelski, Janez Mavri, Robert Vianello, Jernej Stare |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1910 |
Similar Items
-
1-methylhistamine as a potential biomarker of food histamine intolerance. A pilot study
by: Sònia Sánchez-Pérez, et al.
Published: (2022-10-01) -
Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
by: Tana Tandarić, et al.
Published: (2020-08-01) -
Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish
by: Diego Baronio, et al.
Published: (2022-03-01) -
Dual Target Ligands with 4-<i>tert</i>-Butylphenoxy Scaffold as Histamine H<sub>3</sub> Receptor Antagonists and Monoamine Oxidase B Inhibitors
by: Dorota Łażewska, et al.
Published: (2020-05-01) -
Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01)